Is Chemours Stock a Good Investment?

Chemours Investment Advice

To provide specific investment advice or recommendations on Chemours Co stock, we recommend investors consider the following general factors when evaluating Chemours Co. This will help you to make an informed decision on whether to include Chemours in one of your diversified portfolios:

Examine Chemours' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Chemours' leadership team and their track record. Good management can help Chemours navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Diversified Chemicals space and any emerging trends that could impact Chemours' business and its evolving consumer preferences.
Compare Chemours' performance and market position to its competitors. Analyze how Chemours is positioned in terms of product offerings, innovation, and market share.
Check if Chemours pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Chemours' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Chemours Co stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Chemours Co is a good investment.

Sell

Buy

Hold

Our investment recommendation module complements current analysts and expert consensus on Chemours. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Chemours is not overpriced, please confirm all Chemours fundamentals, including its shares owned by institutions, price to sales, and the relationship between the shares outstanding and price to earning . Given that Chemours has a price to earning of 25.49 X, we suggest you to validate Chemours Co market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Market Performance	Modest	Details
Volatility	Not too volatile	Details
Hype Condition	Over hyped	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Below Average	Details
Economic Sensitivity	Responds to the market	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Not Available	Details
Financial Strenth (F Score)	Strong	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine Chemours Stock

Researching Chemours' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 83.0% of the company shares are held by institutions such as insurance companies. The book value of Chemours was currently reported as 4.4. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Chemours last dividend was issued on the 15th of November 2024.

To determine if Chemours is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Chemours' research are outlined below:

	Chemours had very high historical volatility over the last 90 days
	The company generated the yearly revenue of 6.03 B. Annual Net Loss to common stockholders was (238 M) with gross profit of 1.62 B.
	Chemours has a strong financial position based on the latest SEC filings
	Over 83.0% of the company shares are held by institutions such as insurance companies

Chemours uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Chemours Co. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Chemours' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	14th of February 2024 Upcoming Quarterly Report	View
	25th of April 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	14th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Chemours' market capitalization trends

The company currently falls under 'Mid-Cap' category with a market capitalization of 3.28 B.

Chemours' profitablity analysis

The company has Net Profit Margin (PM) of 0.01 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.1 %, which signifies that for every $100 of sales, it has a net operating income of $0.1.

Determining Chemours' profitability involves analyzing its financial statements and using various financial metrics to determine if Chemours is a good buy. For example, gross profit margin measures Chemours' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Chemours' profitability and make more informed investment decisions.

Please note, the presentation of Chemours' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemours' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chemours' management manipulating its earnings.

Basic technical analysis of Chemours Stock

As of the 28th of November, Chemours shows the mean deviation of 2.32, and Risk Adjusted Performance of 0.0656. Chemours technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Chemours' insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chemours insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chemours' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chemours insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Picho Diane I. over two weeks ago Disposition of tradable shares by Picho Diane I. of Chemours at 19.04 subject to Rule 16b-3
		Alvenia Scarborough over a month ago Acquisition by Alvenia Scarborough of 7903 shares of Chemours at 27.5 subject to Rule 16b-3
		Shane Hostetter over three months ago Acquisition by Shane Hostetter of 26709 shares of Chemours subject to Rule 16b-3
		Hostetter Shane over three months ago Insider Trading
		Camela Wisel over a year ago Acquisition by Camela Wisel of 5425 shares of Chemours subject to Rule 16b-3

Chemours' Outstanding Corporate Bonds

Chemours issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chemours uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chemours bonds can be classified according to their maturity, which is the date when Chemours Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	US163851AH15 Corp Bond US163851AH15	View
	US163851AF58 Corp Bond US163851AF58	View
	Chemours 5375 percent Corp Bond US163851AE83	View
	MPLX LP 52 Corp Bond US55336VAL45	View

View All Chemours Corporate Bonds

Understand Chemours' technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Chemours' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0656
	Market Risk Adjusted Performance	0.1767
	Mean Deviation	2.32
	Semi Deviation	2.15
	Downside Deviation	2.38
	Coefficient Of Variation	1326.22
	Standard Deviation	3.45
	Variance	11.91
	Information Ratio	0.0391
	Jensen Alpha	0.077
	Total Risk Alpha	(0.27)
	Sortino Ratio	0.0567
	Treynor Ratio	0.1667
	Maximum Drawdown	18.86
	Value At Risk	(3.97)
	Potential Upside	4.67
	Downside Variance	5.65
	Semi Variance	4.62
	Expected Short fall	(2.95)
	Skewness	1.99
	Kurtosis	6.43

	Risk Adjusted Performance	0.0656
	Market Risk Adjusted Performance	0.1767
	Mean Deviation	2.32
	Semi Deviation	2.15
	Downside Deviation	2.38
	Coefficient Of Variation	1326.22
	Standard Deviation	3.45
	Variance	11.91
	Information Ratio	0.0391
	Jensen Alpha	0.077
	Total Risk Alpha	(0.27)
	Sortino Ratio	0.0567
	Treynor Ratio	0.1667
	Maximum Drawdown	18.86
	Value At Risk	(3.97)
	Potential Upside	4.67
	Downside Variance	5.65
	Semi Variance	4.62
	Expected Short fall	(2.95)
	Skewness	1.99
	Kurtosis	6.43

Consider Chemours' intraday indicators

Chemours intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chemours stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	0.0442
	Daily Balance Of Power	(0.10)
	Rate Of Daily Change	1.0
	Day Median Price	21.89
	Day Typical Price	21.86
	Market Facilitation Index	0.99
	Price Action Indicator	(0.12)
	Period Momentum Indicator	(0.10)

Chemours time-series forecasting models is one of many Chemours' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chemours' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Chemours Stock media impact

Far too much social signal, news, headlines, and media speculation about Chemours that are available to investors today. That information is available publicly through Chemours media outlets and privately through word of mouth or via Chemours internal channels. However, regardless of the origin, that massive amount of Chemours data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Chemours news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Chemours relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Chemours' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Chemours alpha.